Inventor · disambiguated record
Joan M. Robbins
Also filed as: ROBBINS JOAN · ROBBINS JOAN M · ROBBINS JOAN MARIE
5 granted patents·14 pending applications·67 citations·filing 1990–2021
79Inventor score
Files withDENOVO BIOPHARMA LLC3ADVENTRX PHARMACEUTICALS INC2GRUBER HARRY E2TOCAGEN INC2ABINTUS BIO INC1
Top patents by PatentIndex Score
19 records- 0192US6770633B1Ribozyme therapy for the treatment of proliferative skin and eye diseasesIMMUSOL INC·Filed 2000·Granted Aug 3, 2004·48 cites·28 claims
- 0286US9669049B2Compositions comprising gamma retrovirus vectors and methods of treating proliferative disordersGRUBER HARRY E·Filed 2011·Granted Jun 6, 2017·6 cites·27 claims
- 0380US11230719B2Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2015·Granted Jan 25, 2022·2 cites·11 claims
- 0473US9642921B2Cancer combination therapy and recombinant vectorsTOCAGEN INC·Filed 2013·Granted May 9, 2017·1 cites·14 claims
- 0564US2022195460A1Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 0662US2021361691A1Enhanced cancer treatment and monitoring using recombinant vectorsDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 0758US5350864AAminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivativesUS HEALTH·Filed 1990·Granted Sep 27, 1994·10 cites·5 claims
- 0857US2018021365A1Enhanced cancer treatment and monitoring using recombinant vectorsTOCAGEN INC·Filed 2017·Application pending·0 cites
- 0956US2006178326A1Ribozyme therapy for the treatment of proliferative skin and eye diseasesROBBINS JOAN M·Filed 2004·Application pending·0 cites
- 1053US2013130986A1Cancer treatment with recombinant vectorGRUBER HARRY E·Filed 2011·Application pending·0 cites
- 1152US2008045482A1Compositions and methods for the treatment of viral infectionsADVENTRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1249US2005009168A1Methods and apparatus for Adeno associated virus purificationFiled 2004·Application pending·0 cites
- 1347US2023149511A1Treating autoimmune diseases with genetically modified cellsWALLKILL BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1445US2004248830A1Agents that regulate apoptosisFiled 2002·Application pending·0 cites
- 1544US2022090132A1Car t cell methods and constructsABINTUS BIO INC·Filed 2020·Application pending·0 cites
- 1643US2009221594A1Stable pharmaceutical compositions of 5, 10 methylenetrahydrofolateCHEN ANDREW X·Filed 2006·Application pending·0 cites
- 1739US2009291908A1Use of thiophoshonoformic acid and nrtis to treat viral infectionsADVENTRIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1838US2007280944A1Use of 5,10-Methylene Tetrahydrofolate for the Treatment of CancerADVENTRX PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1932US2018169271A1Armed replication-competent oncolytic adenovirusesMEMGEN LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joan M. Robbins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →